SEC23B variants and mRNA expression defects in congenital dyserythropoietic anaemia type II: comprehensive analysis in an Indian cohort

Congenital dyserythropoietic anaemia type II (CDA II) is an autosomal recessive disorder caused by mutations in the SEC23B gene, characterised by moderate to severe anaemia, jaundice, and splenomegaly, primarily due to ineffective erythropoiesis and haemolysis. Complications include iron overload and gallstone formation. This study aimed to characterise the clinical, haematological, and molecular features of CDA II patients and to evaluate the impact of SEC23B variants on mRNA expression as supportive evidence of pathogenicity. A total of 29 CDA II cases were identified. Clinically, patients presented with pallor, icterus, splenomegaly, and indirect hyperbilirubinemia. Haematological analysis revealed hypochromic microcytic anaemia with spherocytes in peripheral smears, with a mean haemoglobin level of 7.54 ± 2.00 g/dL, indicating moderate to severe anaemia. Bone marrow examination showed erythroid hyperplasia with dyserythropoiesis, including > 10% binucleated erythroblasts and karyorrhexis. Serum ferritin was elevated in the majority of patients, consistent with iron overload. Targeted next-generation sequencing identified 13 SEC23B variants. The most frequent mutation, c.1385 A > G (p.Tyr462Cys), was observed in 19 patients in the homozygous state. Two novel variants, including a splice-site mutation (c.2148 + 1G > T) and a nonsense mutation (p.Gln220Ter), were identified and supported by in silico analyses. Quantitative real-time PCR demonstrated reduced SEC23B mRNA levels in all patients, with greater reduction in compound heterozygous patients. One patient underwent hematopoietic stem cell transplantation, three underwent splenectomy, and others were managed with transfusion support. This study expands the mutational spectrum of SEC23B in Indian CDA II patients and highlights the value of gene expression analysis in strengthening variant interpretation and improving diagnostic precision in rare inherited anaemias.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-17
DOI
https://doi.org/10.1038/s41598-026-79723-4
Primary Topic
Hemoglobinopathies and Related Disorders
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

SEC23B variants and mRNA expression defects in congenital dyserythropoietic anaemia type II: comprehensive analysis in an Indian cohort

Tejashree Anil More, Mukul Aggarwal, Bageshree Seth, Sandeep Nemani et al.
1 links
Scientific Reports
Hemoglobinopathies and Related Disorders
article

SEC23B variants and mRNA expression defects in congenital dyserythropoietic anaemia type II: comprehensive analysis in an Indian cohort

Tejashree Anil More, Mukul Aggarwal, Bageshree Seth, Sandeep Nemani, Prabhakar S Kedar, Prachi Kamble, Arati Nandan Saptarshi, Swati Patel, Rashmi Dongerdiye
article en

Abstract

Congenital dyserythropoietic anaemia type II (CDA II) is an autosomal recessive disorder caused by mutations in the SEC23B gene, characterised by moderate to severe anaemia, jaundice, and splenomegaly, primarily due to ineffective erythropoiesis and haemolysis. Complications include iron overload and gallstone formation. This study aimed to characterise the clinical, haematological, and molecular features of CDA II patients and to evaluate the impact of SEC23B variants on mRNA expression as supportive evidence of pathogenicity. A total of 29 CDA II cases were identified. Clinically, patients presented with pallor, icterus, splenomegaly, and indirect hyperbilirubinemia. Haematological analysis revealed hypochromic microcytic anaemia with spherocytes in peripheral smears, with a mean haemoglobin level of 7.54 ± 2.00 g/dL, indicating moderate to severe anaemia. Bone marrow examination showed erythroid hyperplasia with dyserythropoiesis, including > 10% binucleated erythroblasts and karyorrhexis. Serum ferritin was elevated in the majority of patients, consistent with iron overload. Targeted next-generation sequencing identified 13 SEC23B variants. The most frequent mutation, c.1385 A > G (p.Tyr462Cys), was observed in 19 patients in the homozygous state. Two novel variants, including a splice-site mutation (c.2148 + 1G > T) and a nonsense mutation (p.Gln220Ter), were identified and supported by in silico analyses. Quantitative real-time PCR demonstrated reduced SEC23B mRNA levels in all patients, with greater reduction in compound heterozygous patients. One patient underwent hematopoietic stem cell transplantation, three underwent splenectomy, and others were managed with transfusion support. This study expands the mutational spectrum of SEC23B in Indian CDA II patients and highlights the value of gene expression analysis in strengthening variant interpretation and improving diagnostic precision in rare inherited anaemias.

Scientific Reports
Indian Council of Medical Research (IN), Mahatma Gandhi Mission Institute of Health Sciences (IN), ICMR - National Institute of Immunohaemotology (IN), Mahatma Gandhi Mission Medical College and Hospital (IN), All India Institute of Medical Sciences (IN)
Indian Council of Medical Research
Good health and well-being
Hemoglobinopathies and Related Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon